| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
573 |
488 |
$39K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
315 |
278 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
227 |
193 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
339 |
295 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
86 |
76 |
$6K |
| 99051 |
|
551 |
495 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
316 |
287 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
312 |
229 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
319 |
149 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
46 |
44 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
254 |
225 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
13 |
12 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
35 |
29 |
$555.90 |
| 87634 |
|
15 |
15 |
$0.00 |